JP6581586B2 - イソオキサゾリン組成物および動物における寄生虫侵襲の予防または処置におけるその使用 - Google Patents
イソオキサゾリン組成物および動物における寄生虫侵襲の予防または処置におけるその使用 Download PDFInfo
- Publication number
- JP6581586B2 JP6581586B2 JP2016540677A JP2016540677A JP6581586B2 JP 6581586 B2 JP6581586 B2 JP 6581586B2 JP 2016540677 A JP2016540677 A JP 2016540677A JP 2016540677 A JP2016540677 A JP 2016540677A JP 6581586 B2 JP6581586 B2 JP 6581586B2
- Authority
- JP
- Japan
- Prior art keywords
- water
- pharmaceutical composition
- use according
- animal
- isoxazoline compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241001465754 Metazoa Species 0.000 title claims description 70
- 239000000203 mixture Substances 0.000 title claims description 51
- 244000045947 parasite Species 0.000 title claims description 38
- 206010061217 Infestation Diseases 0.000 title claims description 15
- 230000002265 prevention Effects 0.000 title claims description 11
- WEQPBCSPRXFQQS-UHFFFAOYSA-N 4,5-dihydro-1,2-oxazole Chemical compound C1CC=NO1 WEQPBCSPRXFQQS-UHFFFAOYSA-N 0.000 title 1
- -1 methoxyethyl Chemical group 0.000 claims description 104
- 239000003651 drinking water Substances 0.000 claims description 80
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 60
- 239000008194 pharmaceutical composition Substances 0.000 claims description 57
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 claims description 48
- 235000012206 bottled water Nutrition 0.000 claims description 41
- 235000020188 drinking water Nutrition 0.000 claims description 39
- 239000004094 surface-active agent Substances 0.000 claims description 23
- 239000003814 drug Substances 0.000 claims description 21
- 229920000136 polysorbate Polymers 0.000 claims description 21
- 244000144977 poultry Species 0.000 claims description 20
- 229950008882 polysorbate Drugs 0.000 claims description 19
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 claims description 18
- 238000004519 manufacturing process Methods 0.000 claims description 17
- 229940079593 drug Drugs 0.000 claims description 16
- 239000000126 substance Substances 0.000 claims description 16
- 238000001802 infusion Methods 0.000 claims description 13
- 230000009545 invasion Effects 0.000 claims description 13
- 229910052739 hydrogen Inorganic materials 0.000 claims description 12
- 239000001257 hydrogen Substances 0.000 claims description 12
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 12
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 12
- 229920000053 polysorbate 80 Polymers 0.000 claims description 12
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 11
- 229910052736 halogen Inorganic materials 0.000 claims description 10
- 150000002367 halogens Chemical class 0.000 claims description 10
- 125000004970 halomethyl group Chemical group 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 claims description 6
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims description 6
- 125000005767 propoxymethyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])[#8]C([H])([H])* 0.000 claims description 6
- 241000282887 Suidae Species 0.000 claims description 5
- 238000007865 diluting Methods 0.000 claims description 5
- 239000003937 drug carrier Substances 0.000 claims description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 5
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims description 5
- 125000004969 haloethyl group Chemical group 0.000 claims description 4
- 229940068968 polysorbate 80 Drugs 0.000 claims description 4
- 244000000054 animal parasite Species 0.000 claims description 3
- 239000002518 antifoaming agent Substances 0.000 claims description 3
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 3
- 125000006255 cyclopropyl carbonyl group Chemical group [H]C1([H])C([H])([H])C1([H])C(*)=O 0.000 claims description 3
- 125000004672 ethylcarbonyl group Chemical group [H]C([H])([H])C([H])([H])C(*)=O 0.000 claims description 3
- 229920005555 halobutyl Polymers 0.000 claims description 3
- 125000004968 halobutyl group Chemical group 0.000 claims description 3
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims description 3
- 125000004674 methylcarbonyl group Chemical group CC(=O)* 0.000 claims description 3
- 229920000728 polyester Polymers 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 125000004673 propylcarbonyl group Chemical group 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000012453 solvate Substances 0.000 claims description 3
- 125000001424 substituent group Chemical group 0.000 claims description 3
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 claims description 2
- 125000006260 ethylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 230000002335 preservative effect Effects 0.000 claims description 2
- 201000001064 tick infestation Diseases 0.000 claims description 2
- XEUCQOBUZPQUMQ-UHFFFAOYSA-N Glycolone Chemical compound COC1=C(CC=C(C)C)C(=O)NC2=C1C=CC=C2OC XEUCQOBUZPQUMQ-UHFFFAOYSA-N 0.000 claims 2
- 239000000243 solution Substances 0.000 description 37
- 235000013594 poultry meat Nutrition 0.000 description 19
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 15
- 238000000034 method Methods 0.000 description 12
- 241000287828 Gallus gallus Species 0.000 description 11
- 150000002547 isoxazolines Chemical class 0.000 description 11
- 235000013601 eggs Nutrition 0.000 description 9
- 230000037396 body weight Effects 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 229940116333 ethyl lactate Drugs 0.000 description 8
- 210000002445 nipple Anatomy 0.000 description 8
- 241000238876 Acari Species 0.000 description 7
- 239000004480 active ingredient Substances 0.000 description 7
- 235000013330 chicken meat Nutrition 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 241000238421 Arthropoda Species 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 230000003071 parasitic effect Effects 0.000 description 6
- 241000283690 Bos taurus Species 0.000 description 5
- 241001494479 Pecora Species 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 238000007654 immersion Methods 0.000 description 5
- 241001128004 Demodex Species 0.000 description 4
- 241000286209 Phasianidae Species 0.000 description 4
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 4
- 241000282898 Sus scrofa Species 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 239000000693 micelle Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 3
- 241000283707 Capra Species 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 3
- 244000078703 ectoparasite Species 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 238000007910 systemic administration Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- 241000272517 Anseriformes Species 0.000 description 2
- 241000239290 Araneae Species 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 241001481695 Dermanyssus gallinae Species 0.000 description 2
- 241000255925 Diptera Species 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 208000030852 Parasitic disease Diseases 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000000366 juvenile effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 230000017448 oviposition Effects 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 229940068977 polysorbate 20 Drugs 0.000 description 2
- 229940113124 polysorbate 60 Drugs 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229940083037 simethicone Drugs 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- BPFUIWLQXNPZHI-UHFFFAOYSA-N 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-N-[(methoxyamino)methylidene]-2-methylbenzamide Chemical compound C1=C(C)C(C(=O)N\C=N/OC)=CC=C1C1=NOC(C(F)(F)F)(C=2C=C(Cl)C=C(Cl)C=2)C1 BPFUIWLQXNPZHI-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical class CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241001524031 Aedes sp. Species 0.000 description 1
- 241000238679 Amblyomma Species 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 241000256186 Anopheles <genus> Species 0.000 description 1
- 241001520752 Anopheles sp. Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 0 CC(C1)=NOC1(*)C(C=CC=C1)=C*1N Chemical compound CC(C1)=NOC1(*)C(C=CC=C1)=C*1N 0.000 description 1
- KPABKWHCMQUIEJ-UHFFFAOYSA-N CNC(OC#[I])=C Chemical compound CNC(OC#[I])=C KPABKWHCMQUIEJ-UHFFFAOYSA-N 0.000 description 1
- 241000933851 Cochliomyia Species 0.000 description 1
- 241000272201 Columbiformes Species 0.000 description 1
- 241001101077 Crex Species 0.000 description 1
- 241000258922 Ctenocephalides Species 0.000 description 1
- 241000258924 Ctenocephalides felis Species 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 241001480824 Dermacentor Species 0.000 description 1
- 241000202813 Dermatobia Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000322646 Felicola Species 0.000 description 1
- 241001480796 Haemaphysalis Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000238681 Ixodes Species 0.000 description 1
- 241000255777 Lepidoptera Species 0.000 description 1
- 241001414919 Musca sp. Species 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000273374 Ornithonyssus sylviarum Species 0.000 description 1
- 241001674048 Phthiraptera Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001219 Polysorbate 40 Polymers 0.000 description 1
- 241001481703 Rhipicephalus <genus> Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 241000319984 Sarcoptes sp. Species 0.000 description 1
- 241000258242 Siphonaptera Species 0.000 description 1
- BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical class CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 241001494115 Stomoxys calcitrans Species 0.000 description 1
- 206010046865 Vaccinia virus infection Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000002506 adulticidal effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 229940124339 anthelmintic agent Drugs 0.000 description 1
- 239000000921 anthelmintic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 244000079386 endoparasite Species 0.000 description 1
- 230000029578 entry into host Effects 0.000 description 1
- 230000008029 eradication Effects 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- MLBZKOGAMRTSKP-UHFFFAOYSA-N fluralaner Chemical compound C1=C(C(=O)NCC(=O)NCC(F)(F)F)C(C)=CC(C=2CC(ON=2)(C=2C=C(Cl)C=C(Cl)C=2)C(F)(F)F)=C1 MLBZKOGAMRTSKP-UHFFFAOYSA-N 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000005414 inactive ingredient Substances 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 230000000974 larvacidal effect Effects 0.000 description 1
- 210000004880 lymph fluid Anatomy 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 231100000194 ovacidal Toxicity 0.000 description 1
- 230000003151 ovacidal effect Effects 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 description 1
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 description 1
- 229940101027 polysorbate 40 Drugs 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical group O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 229960005480 sodium caprylate Drugs 0.000 description 1
- 235000010268 sodium methyl p-hydroxybenzoate Nutrition 0.000 description 1
- BYKRNSHANADUFY-UHFFFAOYSA-M sodium octanoate Chemical compound [Na+].CCCCCCCC([O-])=O BYKRNSHANADUFY-UHFFFAOYSA-M 0.000 description 1
- OGBHACNFHJJTQT-UHFFFAOYSA-M sodium;4-butoxycarbonylphenolate Chemical compound [Na+].CCCCOC(=O)C1=CC=C([O-])C=C1 OGBHACNFHJJTQT-UHFFFAOYSA-M 0.000 description 1
- PESXGULMKCKJCC-UHFFFAOYSA-M sodium;4-methoxycarbonylphenolate Chemical class [Na+].COC(=O)C1=CC=C([O-])C=C1 PESXGULMKCKJCC-UHFFFAOYSA-M 0.000 description 1
- IXMINYBUNCWGER-UHFFFAOYSA-M sodium;4-propoxycarbonylphenolate Chemical class [Na+].CCCOC(=O)C1=CC=C([O-])C=C1 IXMINYBUNCWGER-UHFFFAOYSA-M 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 125000003003 spiro group Chemical group 0.000 description 1
- 239000004544 spot-on Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- DENPQNAWGQXKCU-UHFFFAOYSA-N thiophene-2-carboxamide Chemical compound NC(=O)C1=CC=CS1 DENPQNAWGQXKCU-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 208000007089 vaccinia Diseases 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
- A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Birds (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Description
R1=ハロゲン、CF3、OCF3、CNであり、
n=0から3の整数、好ましくは1、2または3であり、
R2=C1−C3−ハロアルキル、好ましくはCF3またはCF2Clであり、
T=1以上のラジカルYにより置換されていてもよい5または6員環であり、
Y=メチル、ハロメチル、ハロゲン、CN、NO2、NH2−C=Sであるか、または2個の隣接するラジカルYが、一緒になって、鎖、特に3または4員の鎖を形成し;
Q=1以上のラジカルにより置換されていてもよい、X−NR3R4または5員N−ヘテロアリール環であり;
X=CH2、CH(CH3)、CH(CN)、CO、CSであり、
R3=水素、メチル、ハロエチル、ハロプロピル、ハロブチル、メトキシメチル、メトキシエチル、ハロメトキシメチル、エトキシメチル、ハロエトキシメチル、プロポキシメチル、エチルアミノカルボニルメチル、エチルアミノカルボニルエチル、ジメトキシエチル、プロピニルアミノカルボニルメチル、N−フェニル−N−メチル−アミノ、ハロエチルアミノカルボニルメチル、ハロエチルアミノカルボニルエチル、テトラヒドロフリル、メチルアミノカルボニルメチル、(N,N−ジメチルアミノ)−カルボニルメチル、プロピルアミノカルボニルメチル、シクロプロピルアミノカルボニルメチル、プロペニルアミノカルボニルメチル、ハロエチルアミノカルボニルシクロプロピル、
ここで、ZA=水素、ハロゲン、シアノ、ハロメチル(CF3)であり;
R4=水素、エチル、メトキシメチル、ハロメトキシメチル、エトキシメチル、ハロエトキシメチル、プロポキシメチル、メチルカルボニル、エチルカルボニル、プロピルカルボニル、シクロプロピルカルボニル、メトキシカルボニル、メトキシメチルカルボニル、アミノカルボニル、エチルアミノカルボニルメチル、エチルアミノカルボニルエチル、ジメトキシエチル、プロピニルアミノカルボニルメチル、ハロエチルアミノカルボニルメチル、シアノメチルアミノカルボニルメチルまたはハロエチルアミノカルボニルエチルであるか;
または、R3およびR4は、一緒になって
R1=ハロゲン、CF3、OCF3、CNであり、
n=0から3の整数、好ましくは1、2または3であり、
R2=C1−C3−ハロアルキル、好ましくはCF3またはCF2Clであり、
T=1以上のラジカルYにより置換されていてもよい5または6員環であり、
Y=メチル、ハロメチル、ハロゲン、CN、NO2、NH2−C=Sであるか、または2個の隣接するラジカルYが、一緒になって、鎖CH−CH=CH−CH、N−CH=CH−CH、CH−N=CH−CH、CH−CH=N−CHまたはCH−CH=CH−N、HC=HC−CH、CH−CH=CH、CH=CH−N、N−CH=CHを形成し;
Q=1以上のラジカルZA、ZB、ZDにより置換されていてもよい、X−NR3R4または5員N−ヘテロアリール環であり;
X=CH2、CH(CH3)、CH(CN)、CO、CSであり、
R3=水素、メチル、ハロエチル、ハロプロピル、ハロブチル、メトキシメチル、メトキシエチル、ハロメトキシメチル、エトキシメチル、ハロエトキシメチル、プロポキシメチル、エチルアミノカルボニルメチル、エチルアミノカルボニルエチル、ジメトキシエチル、プロピニルアミノカルボニルメチル、N−フェニル−N−メチル−アミノ、ハロエチルアミノカルボニルメチル、ハロエチルアミノカルボニルエチル、テトラヒドロフリル、メチルアミノカルボニルメチル、(N,N−ジメチルアミノ)−カルボニルメチル、プロピルアミノカルボニルメチル、シクロプロピルアミノカルボニルメチル、プロペニルアミノカルボニルメチル、ハロエチルアミノカルボニルシクロプロピル、
R4=水素、エチル、メトキシメチル、ハロメトキシメチル、エトキシメチル、ハロエトキシメチル、プロポキシメチル、メチルカルボニル、エチルカルボニル、プロピルカルボニル、シクロプロピルカルボニル、メトキシカルボニル、メトキシメチルカルボニル、アミノカルボニル、エチルアミノカルボニルメチル、エチルアミノカルボニルエチル、ジメトキシエチル、プロピニルアミノカルボニルメチル、ハロエチルアミノカルボニルメチル、シアノメチルアミノカルボニルメチルまたはハロエチルアミノカルボニルエチルであるか;または
R3およびR4は、一緒になって
式中、T−1、T−3およびT−4において、ラジカルYは、水素、ハロゲン、メチル、ハロメチル、エチル、ハロエチルである。
ここで、Yは、メチル、臭素、Cl、F、CNまたはC(S)NH2であり、Qは上述のとおりである。)を有する。
R1−−[O−−(CH2)2]x−−OR2 式(III)
(式中、R1=C2H5、R2=Hおよびx=2である。)
の化合物である。
[実施例1]
濃縮溶液の調製
次の手順に従い、本組成物を調製した。
予備希釈(ミセル)溶液の調製
10mLガラスバイアル中でトランスクトールVまたは混合物トランスクトールV/乳酸エチルの何れかにおいて10%w/wフルララネルの溶液を調製し、界面活性剤を添加し、振盪することによって、予備希釈溶液を調製した。その後、精製水を溶媒/界面活性剤混合物に添加し、振盪した。
乳酸エチル/トランスクトールV/Tween 80/精製水中のフルララネルの希釈溶液の安定性試験:第5日に沈殿した希釈溶液EL/TRV−TW80’−W−40−20−40を除き、希釈から5日後に希釈溶液でフルララネルの沈殿物は認められなかったが、28日の期間中のその他の観察中では認められた。
薬用飲用水の安定性
25m管(PE材)中の1μg/mL、2μg/mL、10μg/mLおよび20μg/mLの希釈フルララネル溶液(Tween 80/トランスクトールV75/25の安定性を評価した。これらの溶液は4時間安定であった(処置模倣実験)。
技術的試験
本試験は、それぞれが3階建てになっている4つのバタリー付きのおよそ36000羽の補充鶏(replacement chicken)に対する商業的な家禽舎で行った。4本のPVC行き止まり送水管(長さ78m)によって各バタリーに水が供給された。
105Lに対して計量された、水供給管から来て、水タンクで終わる水用ホースに薬液注入ポンプおよびその保存溶液容器を設置した。
薬物タンクに175Lの水道水を入れた。
有効性試験
産卵鶏の人為的に誘導した家禽類ワクモ侵襲(デルマニサス・ガリナエ(Dermanyssus gallinae))を防除するための、薬用飲用水を介して経口投与されたフルララネルの有効性を調べた。1回で2、1および0.5mgフルララネル/kg BWの用量または2回で1mgフルララネル/kg BW(0.5mg/kg BWを2回)で、AからD群(n=6)を処置した。
平均1日水摂取量を計算するために、投与の3日前にそれぞれにおける飲用水摂取量を測定した。計算したフルララネル濃度まで下記の表で示されるようにフルララネル溶液(10mg/mL)を希釈することによって、薬用水を調製した。
第D0日(D群は第D7日も)に1群あたりに与えられる薬用水の体積は、用量全てを確実に摂取させるために個々の群で前もって測定した平均1日水摂取量計算値のおよそ50%であった。
雌鶏においてフルララネルは耐容性良好であった。
Claims (24)
- 式(I)
(式中、
R1=ハロゲン、CF3、OCF3、CNであり、
n=0から3の整数、好ましくは1、2または3であり、
R2=C1−C3−ハロアルキル、好ましくはCF3またはCF2Clであり、
T=1以上のラジカルYにより置換されていてもよい5または6員環であり、
Y=メチル、ハロメチル、ハロゲン、CN、NO2、NH2−C=Sであるか、または2個の隣接するラジカルYが、一緒になって、鎖、特に3または4員の鎖を形成し;
Q=1以上のラジカルにより置換されていてもよい、X−NR3R4または5員N−ヘテロアリール環であり;
X=CH2、CH(CH3)、CH(CN)、CO、CSであり、
R3=水素、メチル、ハロエチル、ハロプロピル、ハロブチル、メトキシメチル、メトキシエチル、ハロメトキシメチル、エトキシメチル、ハロエトキシメチル、プロポキシメチル、エチルアミノカルボニルメチル、エチルアミノカルボニルエチル、ジメトキシエチル、プロピニルアミノカルボニルメチル、N−フェニル−N−メチル−アミノ、ハロエチルアミノカルボニルメチル、ハロエチルアミノカルボニルエチル、テトラヒドロフリル、メチルアミノカルボニルメチル、(N,N−ジメチルアミノ)−カルボニルメチル、プロピルアミノカルボニルメチル、シクロプロピルアミノカルボニルメチル、プロペニルアミノカルボニルメチル、ハロエチルアミノカルボニルシクロプロピル、
ここで、ZA=水素、ハロゲン、シアノ、ハロメチル(CF3)であり;
R4=水素、エチル、メトキシメチル、ハロメトキシメチル、エトキシメチル、ハロエトキシメチル、プロポキシメチル、メチルカルボニル、エチルカルボニル、プロピルカルボニル、シクロプロピルカルボニル、メトキシカルボニル、メトキシメチルカルボニル、アミノカルボニル、エチルアミノカルボニルメチル、エチルアミノカルボニルエチル、ジメトキシエチル、プロピニルアミノカルボニルメチル、ハロエチルアミノカルボニルメチル、シアノメチルアミノカルボニルメチルまたはハロエチルアミノカルボニルエチルであるか;
または、R3およびR4は、一緒になって
からなる群から選択される置換基を形成する。)のイソオキサゾリン化合物またはそれらの塩もしくは溶媒和物と、ジエチレングリコールモノエチルエーテル、および1つのポリソルベート界面活性剤もしくは2つ以上のその組み合わせを含む医薬的に許容可能な担体と、を含む、医薬組成物の使用であって、
動物の寄生虫侵襲の予防または処置のための飲用水投与用の薬剤の製造のための、前記使用。 - 前記イソオキサゾリン化合物がフルララネルである、請求項1に記載の使用。
- 前記イソオキサゾリン化合物がアフォキソラネルである、請求項1に記載の使用。
- 前記イソオキサゾリン化合物がロチラネルである、請求項1に記載の使用。
- 前記イソオキサゾリン化合物がサロラネルである、請求項1に記載の使用。
- 1.5mg/mLから100mg/mLのイソオキサゾリン化合物を含む、請求項1から5のいずれか1項に記載の使用。
- ジエチレングリコールモノエチルエーテルのポリソルベート界面活性剤に対する比率が、<50:50%w/w、好ましく25/75%w/wである、請求項1から6の何れか1項に記載の使用。
- 前記ポリソルベート界面活性剤がポリソルベート80である、請求項1から7の何れか1項に記載の使用。
- 前記動物がブタおよび家禽類から選択される、請求項1から8の何れか1項に記載の使用。
- 前記動物が産卵鶏である、請求項9に記載の使用。
- 前記寄生虫侵襲がダニ侵襲である、請求項1から10の何れか1項に記載の使用。
- 前記ダニ侵襲が、デルマニサス属(Dermanyssus sp)またはオルニトニサス属(Ornithonyssus sp.)の侵襲である、請求項11に記載の使用。
- 前記医薬品組成物は、処置期間の間、薬用飲用水を介して、単独の動物に対して、動物群に対して、または単一畜舎もしくは単一農場の全動物に対して、利用可能にされる、請求項1から12の何れか1項に記載の使用。
- 前記処置期間が2から24時間、好ましくは4または5から8時間である、請求項13に記載の使用。
- 薬用飲用水の製造のための請求項1から14のいずれか1項に記載の医薬組成物の使用であって、処置期間中に消費される体積に対応する飲用水の体積で処置される動物数に対して有効量のイソオキサゾリン化合物を提供するイソオキサゾリン化合物の濃度になるまで、前記医薬組成物の体積を水で希釈することによって作製される薬用飲用水の製造のための、前記使用。
- 前記処置期間が2から24時間、好ましくは4または5から8時間である、請求項15に記載の使用。
- 動物の寄生虫侵襲の予防または処置のための飲用水投与用の薬剤の製造のための、安定な医薬組成物であって、ジエチレングリコールモノエチルエーテル、および1つのポリソルベート界面活性剤もしくは2つ以上のその組み合わせを含む医薬的に許容可能な担体中に、請求項1〜5のいずれか1項に記載のイソオキサゾリン化合物の1.5mg/mLから100mg/mLの濃縮溶液を含む、安定な医薬組成物。
- ジエチレングリコールモノエチルエーテルのポリソルベート界面活性剤に対する比率が、<50:50%w/w、好ましく25/75%w/wである、請求項17に記載の医薬組成物。
- 前記担体が、約10重量%から約75重量%のジエチレングリコールモノエチルエーテル、および約25重量%から約80重量%のポリソルベート界面活性剤を含む、請求項17に記載の医薬組成物。
- さらに消泡剤、保存剤または抗酸化剤を含む、請求項17に記載の医薬組成物。
- 請求項1から19のいずれか1項に特定される医薬組成物および水の混合物を含有する、薬用飲用水。
- 0.001から1mg/mlの、請求項1から5のいずれか1項に特定されるイソオキサゾリン化合物を含有する、請求項21に記載の薬用飲用水。
- 請求項21または22に記載の薬用飲用水の製造方法であって、水系中で薬液注入ポンプ系を通じて注入することによって、または薬物タンク中で水と混合することによって前記医薬組成物が希釈される、前記製造方法。
- 動物の寄生虫侵襲の予防または処置に使用するための、請求項21または22に記載の薬用飲用水。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13199006.1 | 2013-12-20 | ||
EP13199006 | 2013-12-20 | ||
PCT/EP2014/078634 WO2015091898A1 (en) | 2013-12-20 | 2014-12-19 | Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animals |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2016540809A JP2016540809A (ja) | 2016-12-28 |
JP2016540809A5 JP2016540809A5 (ja) | 2018-01-25 |
JP6581586B2 true JP6581586B2 (ja) | 2019-09-25 |
Family
ID=49880542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016540677A Active JP6581586B2 (ja) | 2013-12-20 | 2014-12-19 | イソオキサゾリン組成物および動物における寄生虫侵襲の予防または処置におけるその使用 |
Country Status (9)
Country | Link |
---|---|
US (4) | US10456358B2 (ja) |
EP (2) | EP4306168A3 (ja) |
JP (1) | JP6581586B2 (ja) |
CN (2) | CN110327468B (ja) |
ES (1) | ES2971061T3 (ja) |
MX (1) | MX2016008118A (ja) |
PL (1) | PL3082867T3 (ja) |
RU (1) | RU2688919C1 (ja) |
WO (1) | WO2015091898A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11883530B2 (en) | 2013-12-20 | 2024-01-30 | Intervet Inc. | Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animals |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2709198C2 (ru) * | 2014-12-22 | 2019-12-17 | Интервет Интернэшнл Б.В. | Применение изоксазолиновых соединений для лечения демодекоза |
CN107750159B (zh) * | 2015-06-23 | 2021-10-29 | 英特维特国际股份有限公司 | 用于消毒的饮用水的含有维生素的异噁唑啉溶液 |
WO2018039508A1 (en) * | 2016-08-25 | 2018-03-01 | Merial, Inc. | Method for reducing unwanted effects in parasiticidal treatments |
CA3042306A1 (en) * | 2016-10-31 | 2018-05-03 | The Scripps Research Institute | Methods and compositions for preventing vector-borne disease transmission |
WO2019091936A1 (en) * | 2017-11-07 | 2019-05-16 | Intervet International B.V. | Injectable isoxazoline pharmaceutical compositions and their use against parasite infestation |
KR20200085295A (ko) * | 2017-11-07 | 2020-07-14 | 인터벳 인터내셔널 비.브이. | 큰 크기의 이속사졸린 입자를 제조하는 방법 |
RU2020122841A (ru) * | 2017-12-15 | 2022-01-18 | Тарсус Фармасьютикалс, Инк. | Изоксазолиновые паразитицидные составы и способы лечения блефарита |
CA3084287A1 (en) | 2017-12-20 | 2019-06-27 | Intervet International B.V. | System for external fish parasite monitoring in aquaculture |
EP3726973A1 (en) * | 2017-12-20 | 2020-10-28 | Intervet International B.V. | Method and system for external fish parasite monitoring in aquaculture |
AU2018390171A1 (en) | 2017-12-20 | 2020-06-11 | Intervet International B.V. | System for external fish parasite monitoring in aquaculture |
US11825814B2 (en) | 2017-12-20 | 2023-11-28 | Intervet Inc. | System for external fish parasite monitoring in aquaculture |
KR102142916B1 (ko) * | 2018-08-17 | 2020-08-10 | 부산대학교 산학협력단 | 상향식 방법을 통한 난용성 약물을 포함하는 나노현탁액의 제조방법 및 이로 제조된 나노현탁액 |
MX2021016055A (es) * | 2019-06-19 | 2022-04-20 | Tarsus Pharmaceuticals Inc | Formulaciones y métodos de parasiticidas de isoxazolina para el tratamiento de la blefaritis. |
CN114306231B (zh) * | 2021-12-29 | 2023-03-24 | 天津市中升挑战生物科技有限公司 | 一种氟雷拉纳杀虫剂及其制备方法和应用 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3727648A1 (de) | 1987-08-19 | 1989-03-02 | Bayer Ag | Neue avermectin derivate, verfahren zu ihrer herstellung und ihre verwendung |
US6998131B2 (en) * | 1996-09-19 | 2006-02-14 | Merial Limited | Spot-on formulations for combating parasites |
CA2558848C (en) | 2004-03-05 | 2013-11-19 | Nissan Chemical Industries, Ltd. | Isoxazoline-substituted benzamide compound and pesticide |
WO2007053902A1 (en) * | 2005-11-10 | 2007-05-18 | Bomac Animal Health Pty Limited | Method of treating parasites |
TW200803740A (en) | 2005-12-16 | 2008-01-16 | Du Pont | 5-aryl isoxazolines for controlling invertebrate pests |
TWI412322B (zh) | 2005-12-30 | 2013-10-21 | Du Pont | 控制無脊椎害蟲之異唑啉 |
TWI430995B (zh) | 2007-06-26 | 2014-03-21 | Du Pont | 萘異唑啉無脊椎有害動物控制劑 |
MX2009013748A (es) * | 2007-06-27 | 2010-01-26 | Du Pont | Metodo de control de plagas en animales. |
TWI556741B (zh) | 2007-08-17 | 2016-11-11 | 英特威特國際股份有限公司 | 異唑啉組成物及其作為抗寄生蟲藥上的應用 |
TWI411395B (zh) | 2007-12-24 | 2013-10-11 | Syngenta Participations Ag | 殺蟲化合物 |
KR101680912B1 (ko) * | 2008-07-09 | 2016-11-29 | 바스프 에스이 | 이속사졸린 화합물 ⅰ을 포함하는 살충 활성 혼합물 |
CA2730405A1 (en) | 2008-07-09 | 2010-01-14 | Nissan Chemical Industries, Ltd. | Production method of isoxazoline-substituted benzoic acid amide compound |
JP5755143B2 (ja) * | 2008-11-19 | 2015-07-29 | メリアル リミテッド | アリールピラゾールおよび/またはホルムアミジンを含む組成物、それらの方法ならびに使用 |
WO2010079077A1 (en) | 2008-12-18 | 2010-07-15 | Novartis Ag | Isoxazolines derivatives and their use as pesticide |
MX2011006568A (es) | 2008-12-19 | 2011-08-03 | Novartis Ag | Compuestos organicos. |
AU2010278948B2 (en) | 2009-07-30 | 2015-04-23 | Boehringer Ingelheim Animal Health USA Inc. | Insecticidal 4-Amino-thieno(2,3-d)-pyrimidine compounds and methods of their use |
EP2579725A2 (en) | 2010-06-09 | 2013-04-17 | Syngenta Participations AG | Pesticidal mixtures including isoxazoline derivatives |
DK178277B1 (da) * | 2010-06-18 | 2015-10-26 | Novartis Tiergesundheit Ag | Diaryloxazolinforbindelser til bekæmpelse af fiskelus |
WO2012089622A2 (en) * | 2010-12-27 | 2012-07-05 | Intervet International B.V. | Topical localized isoxazoline formulation |
HUE058290T2 (hu) * | 2010-12-27 | 2022-07-28 | Intervet Int Bv | Topikális lokalizált izoxazolin formuláció, amely tartalmaz glikofurolt |
CN103347880B (zh) | 2011-02-10 | 2015-11-25 | 瑞士诺华动物保健有限公司 | 用于控制无脊椎害虫的异噁唑啉衍生物 |
RS54860B1 (sr) | 2011-03-10 | 2016-10-31 | Zoetis Services Llc | Spirociklični derivati izoksazolina kao antiparazitska sredstva |
US9247740B2 (en) | 2011-08-25 | 2016-02-02 | Syngenta Participations Ag | Isoxazoline derivatives as insecticidal compounds |
WO2013026695A1 (en) | 2011-08-25 | 2013-02-28 | Syngenta Participations Ag | Isoxazoline derivatives as insecticidal compounds |
KR102081036B1 (ko) | 2011-09-12 | 2020-02-24 | 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 | 이속사졸 활성화제를 포함하는 구충 조성물, 이의 용도 및 구충 방법 |
BR112014007847A2 (pt) | 2011-10-03 | 2017-04-18 | Syngenta Participations Ag | derivados de isoxazolina como compostos inseticidas |
AU2013245011B2 (en) | 2012-04-04 | 2017-11-23 | Intervet International B.V. | Solid oral pharmaceutical compositions for isoxazoline compounds |
EP3052080A1 (en) | 2013-09-30 | 2016-08-10 | Zoetis Services LLC | Long-acting spiro-isoxazoline formulations |
JP6506763B2 (ja) | 2013-12-20 | 2019-04-24 | インターベット インターナショナル ベー. フェー. | 家禽類における節足動物侵襲の処置または予防のためのイソオキサゾリン誘導体の使用 |
WO2015091898A1 (en) | 2013-12-20 | 2015-06-25 | Intervet International B.V. | Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animals |
-
2014
- 2014-12-19 WO PCT/EP2014/078634 patent/WO2015091898A1/en active Application Filing
- 2014-12-19 US US15/102,414 patent/US10456358B2/en active Active
- 2014-12-19 PL PL14815365.3T patent/PL3082867T3/pl unknown
- 2014-12-19 MX MX2016008118A patent/MX2016008118A/es active IP Right Grant
- 2014-12-19 RU RU2016129474A patent/RU2688919C1/ru active
- 2014-12-19 ES ES14815365T patent/ES2971061T3/es active Active
- 2014-12-19 EP EP23206906.2A patent/EP4306168A3/en active Pending
- 2014-12-19 EP EP14815365.3A patent/EP3082867B1/en active Active
- 2014-12-19 JP JP2016540677A patent/JP6581586B2/ja active Active
- 2014-12-19 CN CN201910734505.3A patent/CN110327468B/zh active Active
- 2014-12-19 CN CN201480068585.9A patent/CN105813651B/zh active Active
-
2019
- 2019-09-13 US US16/570,633 patent/US20200000720A1/en not_active Abandoned
-
2021
- 2021-07-30 US US17/390,296 patent/US11883530B2/en active Active
-
2023
- 2023-12-06 US US18/530,282 patent/US20240122849A1/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11883530B2 (en) | 2013-12-20 | 2024-01-30 | Intervet Inc. | Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animals |
Also Published As
Publication number | Publication date |
---|---|
US20210353537A1 (en) | 2021-11-18 |
US20200000720A1 (en) | 2020-01-02 |
MX2016008118A (es) | 2016-09-16 |
RU2016129474A (ru) | 2018-01-25 |
EP3082867A1 (en) | 2016-10-26 |
WO2015091898A1 (en) | 2015-06-25 |
RU2019114223A (ru) | 2019-06-28 |
US20160317439A1 (en) | 2016-11-03 |
US11883530B2 (en) | 2024-01-30 |
CN110327468B (zh) | 2023-04-28 |
EP4306168A3 (en) | 2024-03-13 |
EP3082867B1 (en) | 2024-01-17 |
PL3082867T3 (pl) | 2024-05-13 |
EP4306168A2 (en) | 2024-01-17 |
ES2971061T3 (es) | 2024-06-03 |
CN110327468A (zh) | 2019-10-15 |
RU2688919C1 (ru) | 2019-05-23 |
JP2016540809A (ja) | 2016-12-28 |
US10456358B2 (en) | 2019-10-29 |
CN105813651A (zh) | 2016-07-27 |
US20240122849A1 (en) | 2024-04-18 |
CN105813651B (zh) | 2021-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6581586B2 (ja) | イソオキサゾリン組成物および動物における寄生虫侵襲の予防または処置におけるその使用 | |
JP6506763B2 (ja) | 家禽類における節足動物侵襲の処置または予防のためのイソオキサゾリン誘導体の使用 | |
US11878006B2 (en) | Isoxazoline solution containing vitamin E for use with sanitized drinking water | |
RU2791637C2 (ru) | Изоксазолиновые композиции и их применение в профилактике или лечении паразитарных инвазий животных | |
US11903962B1 (en) | Isoxazoline complexes and compositions thereof | |
RU2796536C9 (ru) | Применение изоксазолиновых соединений на домашней птице | |
RU2796536C2 (ru) | Применение изоксазолиновых соединений на домашней птице | |
WO2021122521A1 (en) | Composition for lice control in poultry |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20171207 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20171207 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180911 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20181128 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190208 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190305 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190528 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20190806 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190830 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6581586 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R153 | Grant of patent term extension |
Free format text: JAPANESE INTERMEDIATE CODE: R153 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |